Huakang Biomedical Holdings Company Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 26.13 million compared to CNY 21.97 million a year ago. Net loss was CNY 4.22 million compared to CNY 11.63 million a year ago.

Basic loss per share from continuing operations was CNY 0.0106 compared to CNY 0.0291 a year ago.